GERN Competitors & Alternatives
Compare Geron Corporation with similar stocks in the same industry
Biotechnology
GERN
Main Stock$1.13
Tradestie Score
51
Market Cap
$899.60M
Revenue Growth
0.2%
Analyst Upside
+276.1%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KURA
Kura Oncology, Inc.
|
$9.86
|
$798.53M | - | 60 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$10.43
|
$791.82M | - | 44 | Compare |
|
OLMA
Olema Pharmaceuticals, Inc. Common Stock
|
$7.02
|
$757.72M | - | 47 | Compare |
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$19.20
|
$748.90M | - | 53 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$17.03
|
$726.21M | 16.4 | 51 | Compare |
|
ANL
ANL
|
$10.58
|
$725.12M | - | 69 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$25.51
|
$718.62M | 10.7 | 29 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$20.87
|
$715.25M | - | 50 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 51 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$126.39
|
$699.30M | - | 68 | Compare |
More GERN Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry